Low molecular weight heparin in children

  title={Low molecular weight heparin in children},
  author={M. Albisetti and M. Andrew},
  journal={European Journal of Pediatrics},
  • M. Albisetti, M. Andrew
  • Published 2001
  • Medicine
  • European Journal of Pediatrics
  • Abstract. Low molecular weight heparins potentially have significant advantages over unfractionated heparin and oral anticoagulants for both the prevention and treatment of thromboembolic events in children. Compared to standard heparin, low molecular weight heparins have superior bioavailability, a longer half-life, and a dose-independent clearance, which results in a more predictable anticoagulant response. Low molecular weight heparins are administered subcutaneously and require minimal… CONTINUE READING